Skip to main content
Cancer Biomarkers: Section A of Disease Markers logoLink to Cancer Biomarkers: Section A of Disease Markers
. 2015;15(5):535–542. doi: 10.3233/CBM-150492

MiR-204 regulates HMGA2 expression and inhibits cell proliferation in human thyroid cancer

ZY Wu a, SM Wang a, ZH Chen b, SX Huv a, K Huang a, BJ Huang a, JL Du a, CM Huang a, L Peng a, ZX Jian a, G Zhao a,*
PMCID: PMC12965452  PMID: 26406941

Abstract

BACKGROUND: Analysis using publicly available algorithms has found that high mobility group AT-hook 2 (HMGA2), a key transcriptional regulatory factor, is a potential target of microRNA-204 (miR-204). Some studies have shown that both miR-204 and HMGA2 are associated with cancer development.

OBJECTIVE: We examined the possible relationship between miR-204 and HMGA2 in the development of thyroid cancer.

METHODS: We assessed miR-204 expression in thyroid cancer specimens and cell lines using real-time polymerase chain reaction (PCR). Luciferase reporter assay was used to confirm the target associations. The effect of miR-204 on cell proliferation was confirmed with tetrazolium and colony formation assays. Gene and protein expression were examined using real-time PCR and western blotting, respectively.

RESULTS: MiR-204 was downregulated in the thyroid cancer specimens and cell lines, and targeted the 3^\prime untranslated region of HMGA2 directly. MiR-204 overexpression decreased cyclin D1 and Ki67 expression and increased P21 expression, which subsequently inhibited thyroid cancer cell proliferation.

CONCLUSIONS: Our findings suggest that miR-204 plays a protective role by inhibiting thyroid cancer cell proliferation, and may identify new targets for anti-cancer treatment.

Keywords: MiR-204, HMGA2, proliferation, thyroid cancer

Full Text

The Full Text of this article is available as a PDF (567.9 KB).


Articles from Cancer Biomarkers: Section A of Disease Markers are provided here courtesy of SAGE Publications

RESOURCES